Trials / Active Not Recruiting
Active Not RecruitingNCT05387980
A Study to Learn About the Study Medicine (CIBINQO) in People With Atopic Dermatitis.
CIBINQO® TABLETS SPECIAL INVESTIGATION
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,128 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn about the safety and effectiveness (how well the study treatment works) of the study medicine (CIBINQO) for the potential treatment of atopic dermatitis in people under Japanese medical practice.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CIBINQO | Patients receiving CIBINQO tablets by mouth for the treatment of Atopic Dermatitis. |
Timeline
- Start date
- 2022-04-19
- Primary completion
- 2028-11-01
- Completion
- 2028-11-01
- First posted
- 2022-05-24
- Last updated
- 2026-03-19
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05387980. Inclusion in this directory is not an endorsement.